Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mazzei

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Archiv Der Pharmazie|December 25, 2015
Phenylhydrazones as Correctors of a Mutant Cystic Fibrosis Transmembrane Conductance RegulatorErika Nieddu, Benedetta Pollarolo, Marco T Mazzei, et al.
Journal of Global Antimicrobial Resistance|July 23, 2017
Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogenA M Bal, M Z David, J Garau, et al.
Journal of Medicinal Chemistry|September 23, 2000
Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compoundsL Messori, F Abbate, G Marcon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinomaR Rosso, T Mazzei, A Sobrero, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1990
Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemiaE Mini, M Coronnello, S Carotti, et al.
Anticancer Research|April 12, 2003
Oxaliplatin plus raltitrexed in the treatment of patients with advanced colorectal cancer: a phase II studyA Martoni, E Mini, C Pinto, et al.
Future Medicinal Chemistry|December 16, 2014
The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channelErika Nieddu, Benedetta Pollarolo, Marco T Mazzei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinomaA Martoni, E Mini, C Pinto, et al.
Chemmedchem|August 29, 2012
Asymmetric 4-aryl-1,4-dihydropyridines potentiate mutant cystic fibrosis transmembrane conductance regulator (CFTR)Michele Giampieri, Nicolas Vanthuyne, Erika Nieddu, et al.
Anti-Cancer Drugs|June 1, 1995
Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assayI A Cree, M Pazzagli, E Mini, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Archiv Der Pharmazie|December 25, 2015
Phenylhydrazones as Correctors of a Mutant Cystic Fibrosis Transmembrane Conductance RegulatorErika Nieddu, Benedetta Pollarolo, Marco T Mazzei, et al.
Journal of Global Antimicrobial Resistance|July 23, 2017
Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogenA M Bal, M Z David, J Garau, et al.
Journal of Medicinal Chemistry|September 23, 2000
Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compoundsL Messori, F Abbate, G Marcon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinomaR Rosso, T Mazzei, A Sobrero, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1990
Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemiaE Mini, M Coronnello, S Carotti, et al.
Anticancer Research|April 12, 2003
Oxaliplatin plus raltitrexed in the treatment of patients with advanced colorectal cancer: a phase II studyA Martoni, E Mini, C Pinto, et al.
Future Medicinal Chemistry|December 16, 2014
The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channelErika Nieddu, Benedetta Pollarolo, Marco T Mazzei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinomaA Martoni, E Mini, C Pinto, et al.
Chemmedchem|August 29, 2012
Asymmetric 4-aryl-1,4-dihydropyridines potentiate mutant cystic fibrosis transmembrane conductance regulator (CFTR)Michele Giampieri, Nicolas Vanthuyne, Erika Nieddu, et al.
Anti-Cancer Drugs|June 1, 1995
Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assayI A Cree, M Pazzagli, E Mini, et al.
Pageof 11